Yu Min, MD

Chengdu, Sichuan

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 2860 - Multifunctional Ruthenium Covalent Organic Framework Sequentially Sensitize Radio-Radio-Dynamic-Immunotherapy against Cancer

  Monday, September 30, 2024
  5:00 PM – 6:00 PM ET